(Q38394262)

2 September 2017

Utility of serodiagnostics designed for use in the United States for detection of Lyme borreliosis acquired in Europe and vice versa (English)

1 reference

2 September 2017

0 references

9

Franc Strle

1 reference

2 September 2017

1

Gary P Wormser

1 reference

2 September 2017

10

Gerold Stanek

1 reference

2 September 2017

Aimee T Tang

2

1 reference

2 September 2017

Natasha R Schimmoeller

3

1 reference

2 September 2017

Susan Bittker

4

1 reference

2 September 2017

Denise Cooper

5

1 reference

2 September 2017

Paul Visintainer

6

1 reference

2 September 2017

Maria E Aguero-Rosenfeld

7

1 reference

2 September 2017

Katarina Ogrinc

8

1 reference

2 September 2017

12 November 2013

1 reference

Medical Microbiology and Immunology

2 September 2017

1 reference

2 September 2017

203

1 reference

2 September 2017

1

1 reference

2 September 2017

65-71

1 reference

https://scigraph.springernature.com/pub.10.1007/s00430-013-0315-0

2 September 2017

0 references

cites work

Epidemiology of lyme borreliosis

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0315-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0315-0

Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0315-0

Prospective study of serologic tests for lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0315-0

Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0315-0

Borrelia burgdorferi VlsE antigen for the serological diagnosis of Lyme borreliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0315-0

C6 peptide ELISA test in the serodiagnosis of Lyme borreliosis in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0315-0

Two-Tiered Antibody Testing for Lyme Disease With Use of 2 Enzyme Immunoassays, a Whole-Cell Sonicate Enzyme Immunoassay Followed by a VlsE C6 Peptide Enzyme Immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0315-0

Antigenic composition of Borrelia burgdorferi during infection of SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0315-0

Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0315-0

Evaluation of commercial screening tests and blot assays for the diagnosis of Lyme borreliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00430-013-0315-0

Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24218117

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00430-013-0315-0

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference